BRIEF published on 10/08/2024 at 08:05, 2 years 1 month ago Eckert & Ziegler and GlyTherix Sign Lutetium-177 Supply Agreement Clinical Trials Cancer Treatment Radiopharmaceuticals Lutetium-177 GlyTherix Partnership
BRIEF published on 10/08/2024 at 08:05, 2 years 1 month ago Eckert & Ziegler et GlyTherix signent un accord de fourniture de lutétium-177 Essais Cliniques Traitement Du Cancer Produits Radiopharmaceutiques Lutetium-177 Partenariat GlyTherix
PRESS RELEASE published on 10/08/2024 at 08:00, 2 years 1 month ago Eckert & Ziegler and GlyTherix Sign Agreement for Lutetium-177 Supply Eckert & Ziegler and GlyTherix sign global agreement for Lutetium-177 supply, aiming for innovative cancer treatments with targeted radiotherapy Clinical Trials Eckert & Ziegler Lutetium-177 GlyTherix Radiotherapy
BRIEF published on 10/02/2024 at 11:48, 2 years 1 month ago Eckert & Ziegler: Spin-off of Pentixapharm AG Registered Frankfurt Stock Exchange Spin-off Commercial Register Pentixapharm AG Share Allocation
BRIEF published on 10/02/2024 at 11:48, 2 years 1 month ago Eckert & Ziegler : enregistrement de la scission de Pentixapharm AG Bourse De Francfort Spin Off Répartition Des Actions Registre Du Commerce Pentixapharm AG
PRESS RELEASE published on 10/02/2024 at 11:43, 2 years 1 month ago Eckert & Ziegler: Spin-off of Pentixapharm AG Registered with the Commercial Register Eckert & Ziegler SE successfully completes the spin-off of Pentixapharm AG, transferring shares to Pentixapharm Holding AG as per the approved resolution at the Annual General Meeting Shareholders Spin-off Commercial Register Eckert & Ziegler SE Pentixapharm AG
BRIEF published on 08/20/2024 at 17:05, 2 years 2 months ago Eckert & Ziegler Opens New Radiopharmaceutical Facilities in Dresden Expansion Investment Radiopharmaceuticals Employment Dresden
BRIEF published on 08/20/2024 at 17:05, 2 years 2 months ago Eckert & Ziegler ouvre de nouvelles installations radiopharmaceutiques à Dresde Investissement Expansion Emploi Produits Radiopharmaceutiques Dresde
PRESS RELEASE published on 08/20/2024 at 17:00, 2 years 2 months ago Eckert & Ziegler opens new facilities for radiopharmaceutical plant engineering in Dresden Eckert & Ziegler inaugurates new radiopharmaceutical plant engineering facilities in Dresden, investing up to €50 million for further expansion and job creation Expansion Eckert & Ziegler Inauguration Radiopharmaceuticals Dresden
BRIEF published on 08/13/2024 at 09:05, 2 years 2 months ago Eckert & Ziegler Becomes European Contract Manufacturer for Telix's Phase III ProstACT GLOBAL Study Clinical Study Radiopharmaceuticals Contract Manufacturing Prostate Cancer Lu-177
Published on 11/11/2026 at 03:30, 5 hours 14 minutes ago CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary
Published on 11/11/2026 at 00:40, 8 hours 4 minutes ago Upgraded Tunkillia MRE Validates Optimised Scoping Study
Published on 11/10/2026 at 23:30, 9 hours 14 minutes ago CCL Industries Announces 2026 Third Quarter Results
Published on 11/10/2026 at 23:00, 9 hours 44 minutes ago Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/10/2026 at 23:00, 9 hours 44 minutes ago Battery X Metals Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/11/2026 at 08:31, 13 minutes ago Delivery Hero SE: Notice to the Bondholders of the EUR 500 million Convertible Bonds due 2029 (ISIN DE000A3MP437 – Common Code 238511097 – German Securities Code (WKN) A3MP43)
Published on 11/11/2026 at 08:30, 14 minutes ago Delivery Hero SE: Notice to the Bondholders of the EUR 1,000 million Convertible Bonds due 2030 (ISIN DE000A30V5R1 – Common Code 258943848 – German Securities Code (WKN) A30V5R)
Published on 11/11/2026 at 08:30, 14 minutes ago Delivery Hero SE: Notice to the Bondholders of the EUR 750 million Convertible Bonds due 2028 (ISIN DE000A3H2WQ0 – Common Code 220637387 – German Securities Code (WKN) A3H2WQ)
Published on 11/11/2026 at 08:30, 14 minutes ago aap Implantate AG: Management Board refines 2026 forecast and provides first outlook for 2027 – Ambition 2030: Revenue of at least EUR 21 million with an EBITDA margin of 17.5% to 22.5%
Published on 11/11/2026 at 08:30, 14 minutes ago Delivery Hero SE: Notice to the Bondholders of the EUR 875 million Convertible Bonds due 2027 (ISIN DE000A254Y92 – Common Code 210751831 – German Securities Code (WKN) A254Y9)
Published on 11/10/2026 at 18:00, 14 hours 44 minutes ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 14 hours 59 minutes ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 15 hours 9 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 15 hours 12 minutes ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
